# Functional Magnetic Resonance Imaging (fMRI) Investigation of Nicotine Withdrawal Symptoms

> **NCT00657020** · PHASE4 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 23 (actual)

## Conditions studied

- Smoking

## Interventions

- **DRUG:** Nicotine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00657020
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-09
- **Primary completion:** 2008-02
- **Final completion:** 2008-02
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2015-03-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00657020

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00657020, "Functional Magnetic Resonance Imaging (fMRI) Investigation of Nicotine Withdrawal Symptoms". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00657020. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*